Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Crohn’s & Colitis Foundation Applauds Senate HELP Committee for Including the Safe Step Act in PBM Reform Legislation

Legislation will give patients and their doctors a process to seek exception to Step Therapy requirements that may delay necessary care.

May 16, 2023

Crohn’s & Colitis Foundation Urges Congress To Pass Legislation to Reform Pharmacy Benefit Manager (PBM) Industry

The Crohn's & Colitis Foundation advocates for reform in the Pharmacy Benefit Manager (PBM) industry due to the negative impact it has on patients' access to medicine.

May 1, 2023

Crohn’s & Colitis Foundation Makes Statement in Support of FDA’s Role in Safeguarding Patients

Last week, in an unprecedented decision, a Texas federal judge invalidated the Food and Drug Administration’s (FDA) approval of a drug that was approved by the agency in 2000.

April 12, 2023

Crohn’s & Colitis Foundation Makes Statement About Crohn’s Disease Patient Fired from Walmart

April 3, 2023, New York, NY – Last week, the U.S. Equal Employment Opportunity Commission (EEOC) sued Walmart for firing a North Carolina employee with Crohn’s disease after the company allegedly refused to grant her disability-related leave.

April 4, 2023

Crohn’s & Colitis Foundation’s IBD Ventures Invests $2.4 Million in Developing Novel Products to Address Unmet Needs of IBD Patients

Since 2017, IBD Ventures Has Invested Over $9 Million In R&D Funding to Portfolio Companies

March 21, 2023

Early Life Stress in Mice Impairs Gut Immune Regulation and Leads to Worsened Future Colonic Inflammation

New York, NY, March 14, 2023 – Early life stress (ELS) in mice can disrupt the gut immune response, leading to longer-lasting intestinal inflammation and a worsened future disease state than control mice not exposed to ELS, according to a new study published in Inflammatory B

March 15, 2023

Crohn’s & Colitis Foundation announces Sharon Lungrin as new member of senior leadership team

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today

July 18, 2022

Veterans with chronic intestinal diseases find hope and help through new support group

For this year’s World Inflammatory Bowel Disease (IBD) day on May 19th, Veterans have a new way to receive support.

May 19, 2022

Pomegranate extract dietary supplement lowers Inflammation and reduces disease severity in a pre-clinical model of colitis

NEW YORK, NY – Dietary supplementation of pomegranate extract decreased disease severity and lowered inflammation in mice with colitis, according to a new study published in Molecular Nutrition and Food Research and

February 25, 2022

First-of-its-kind technology provides individualized, actionable insights on dose and interval for infliximab

Prometheus Laboratories recently announced the launch of PredictrPK IFX, which uses a machine learning algorithm to combine patient weight, current dose and interval, measured serum IFX, measured antibodies-to-infliximab and albumin levels to predict optimal, individualized infliximab dosing.

February 23, 2022